Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 07, 2021

SELL
$242.95 - $284.63 $29,396 - $34,440
-121 Closed
0 $0
Q4 2020

Jan 15, 2021

SELL
$236.26 - $355.63 $20,318 - $30,584
-86 Reduced 41.55%
121 $30,000
Q4 2019

Mar 19, 2020

BUY
$220.06 - $304.07 $45,552 - $62,942
207 New
207 $61,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $26.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Sowa Financial Group, Inc. Portfolio

Follow Sowa Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sowa Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sowa Financial Group, Inc. with notifications on news.